GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Other Net Income (Loss)

Concord Biotech (BOM:543960) Other Net Income (Loss) : ₹0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Other Net Income (Loss)?

Concord Biotech's Other Net Income (Loss) for the six months ended in Mar. 2024 was ₹0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

Concord Biotech's quarterly Other Net Income (Loss) declined from Mar. 2023 (₹0 Mil) to Sep. 2023 (₹0 Mil) but then increased from Sep. 2023 (₹0 Mil) to Mar. 2024 (₹0 Mil).

Concord Biotech's annual Other Net Income (Loss) stayed the same from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹0 Mil) but then increased from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹0 Mil).

Concord Biotech Other Net Income (Loss) Historical Data

The historical data trend for Concord Biotech's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Other Net Income (Loss) Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Other Net Income (Loss)
- - - - -

Concord Biotech Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial - - - - -

Concord Biotech Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Biotech Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech (BOM:543960) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Other Net Income (Loss)
Comparable Companies
BOM:540701 BOM:543434 NSE:ZOTA BOM:531349 NSE:BALAXI BOM:500259 BOM:524717 BOM:532890 BOM:540679 BOM:524663 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
CONCORDBIO:India
Address
Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Website
https://www.concordbiotech.com
Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines